Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 11/21/24 → 11/20/26 |
Funding
- Pharmaceutical Research Associates: $21,018.00
Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients with Motor Complications
- Slevin, John (PI)